We are pleased to announce our 2018 World Preclinical Congress Distinguished Faculty:
Aaron Wright, PhD, Principal Investigator and Group Leader, Chemical Biology & Exposure Sciences Group, Pacific Northwest National Laboratory
Adam S. Lazorchak, PhD, Senior Scientist, Immunology & Translational Sciences, Curis, Inc.
Alain Brisson, PhD, Emeritus Professor, UMR-CBMN CNRS, University of Bordeaux
Alejandro Villagra, PhD, Assistant Professor, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University
Aleksandra Baranczak, PhD, Senior Scientist, Chemistry and Chemical Biology, AbbVie
Alex Chenchik, PhD, President, CSO, Cellecta, Inc.
Alex Walsh, PhD, Assistant Scientist, Department of Medical Engineering, Morgridge Institute for Research, University of Wisconsin - Madison
Alexander Baker, Research Scientist, Molly Shoichet Laboratory, Institute of Biomaterials and Biomedical Engineering, Chemical Engineering & Applied Chemistry, The Donnelly Centre, University of Toronto
Alexander (Sasha) Kabanov, PhD, DrSci, MAE, Director, Center for Nanotechnology in Drug Delivery; Co-Director, Carolina Institute for Nanomedicine; Mescal S. Ferguso Distinguished Professor, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
Alyssa Schwartz, Graduate Research Assistant, Chemical Engineering, University of Massachusetts Amherst
Amanda Benjamin, Head, Alliance and Project Management, Drug Safety and Metabolism, AstraZeneca
Amantha Thathiah, PhD, Assistant Professor, Department of Neurobiology, Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine
Anand Subramony, PhD, Vice President, Novel Product Technologies, MedImmune
Andrea Alms, Consultant, Molding Component Business Department, Kuraray Co. Ltd
Andrew Hoffman, DVM, DVSc, Diplomate ACVIM, Director of the Regenerative Medicine Laboratory, Professor, Large Animal Medicine, Department of Clinical Sciences, Tufts University Cummings School of Veterinary Medicine
Andrew Hope, PhD, Vice President, Business Development, Cyclica Inc
Andrew Sawyer, PhD, Research Team Lead, Discovery, Merrimack
Andrew Weinberg, PhD, Chief, Laboratory of Basic Immunology, Providence Health & Services
Andrew Whale, PhD, Senior Scientist, Manager, Preclinical, Immunocore Ltd.
Anita Seshire, PhD, Lab Head, Cellular Pharmacology, Translational Innovation Platform Oncology, Merck KGaA
Anja Baumgart, Business Development Manager, Sales, ProQinase
Anna Jezierski, PhD, Research Associate, Human Health Therapeutics, National Research Council of Canada
Anne Mai Wassermann, PhD, Associate Principal Scientist, Cheminformatics, Merck
Annette Gilchrist, PhD, Professor, Pharmacology, Midwestern University
Arantza Muriana, MBA, CEO, Biobide USA
Arijit Chakravarty, CEO, Fractal Therapeutics
Arvind Rao, PhD, Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center
Asano Asami-Odaka, PhD, Associate Director, Ikeya Project, T-CiRA, Regenerative Medicine Unit, Takeda Pharmaceutical Company Limited
Ashley Rae Kark, MBS, Director, Corporate Relations, Scientist.com
Atli Thorarensen, PhD, Research Fellow, BioTc Medicinal Chemistry, Pfizer
Avi Smith, MA, Senior Research Technician, Tufts University
Baptiste Lacoste, PhD, Assistant Professor, Cellular and Molecular Medicine/Neuroscience Program, The University of Ottawa/Ottawa Hospital Research Institute
Barbara Joyce-Shaikh, Associate Principal Scientist, Merck Research Laboratories
Barbara K. Sosnowski, PhD, Vice President and Global Head, External R&D Innovation, Pharmatherapeutics and WRD External Partnerships, Pfizer, Inc.
Barry Morgan, PhD, Professor, Center for Drug Discovery, Bayer College of Medicine
Benjamin Cuiffo, PhD, Principal Scientist, Oncology, Biomodels, LLC
Bhagat Singh, PhD, Research Fellow, Neurobiology, Clifford Wolf’s Lab, Boston Children’s Hospital, Harvard Medical School
Bilada Bilican, PhD, Investigator II, Neuroscience, Novartis Institutes for BioMedical Research (NIBR)
Brandon Farley, PhD, Senior Scientist, SAGE Therapeutics
Britnie James, PhD, Senior Vice President, Pre-Clinical Services, Immunology and Oncology, Pre-Clinical Laboratory Services, MD Biosciences, Inc.
Caghan Kizil, PhD, Helmholtz Young Investigator Group Leader, German Center for Neurodegenerative Diseases (DZNE) within Helmholtz Association
Carlo Cusulin, PhD, Senior Scientist, Disease Relevant Cellular Assays, Chemical Biology, F. Hoffmann-La Roche
Catherine Lebrun, PhD, Medicinal Chemist, Medicinal Chemistry, EMD-SERONO
Chao Ma, PhD, Postdoc, Weiqiang Chen Laboratory, Department of Mechanical and Aerospace Engineering, New York University
Chao Zhou, PhD, Associate Professor, Founding Member, Department of Bioengineering, Department of Electrical and Computer Engineering, Lehigh University
Chee Yeun Chung, PhD, Scientific Co-Founder and Associate Director, Discovery Biology, Yumanity Therapeutics
Chen Zhu, PhD, Lab Head, Sanofi Oncology
Choi-Fong Cho, PhD, Instructor, Department of NeurosBaptiste Lacoste, PhD, Assistant Professor, Cellular and Molecular Medicine/ Neuroscience Program, The University of Ottawa/Ottawa Hospital Research Institute
Christian Klose, PhD, Head, Research and Development, Lipotype GmbH
Christopher Hartshorn, PhD, Program Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Christopher Untucht, PhD, Senior Scientist, Head of Cell Imaging Platform, Neuroscience Discovery Core Technologies, AbbVie Deutschland GmbH & Co. KG
Chulhee Choi, MD, PhD, Professor, Department of Bio and Brain Engineering, KAIST, Korea
Craig W. Lindsley, PhD, Vanderbilt Center for Neuroscience Drug Discovery
Cynthia Reinhart-King, PhD, Cornelius Vanderbilt Professor of Engineering, Biomedical Engineering, Vanderbilt University
Dana Larocca, PhD, Vice President, Discovery Research, AgeX Therapeutics, Inc.
Daniel Haag, PhD, CSO, NeuCyte, Inc.
Daniel Irimia, MD, PhD, Associate Professor, Division of Surgery, Science & Bioengineering, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children – Boston
Daniel V. LaBarbera, PhD, Associate Professor, Drug Discovery and Medicinal Chemistry; Director, High-Throughput Screening and Chemical Biology Core Facility, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado
Daniel Nomura, PhD, Associate Professor, Chemistry, Molecular and Cell Biology, and Nutritional Sciences and Toxicology, University of California, Berk
Danilo A. Tagle, PhD, Associate Director for Special Initiatives, National Center for Advancing Translational Sciences, National Institutes of Health
Danilo Maddalo, PhD, Lab Head, ONC Pharmacology, Novartis Institutes for BioMedical Research, Novartis Pharma AG
Danilo Tagle, PhD, Associate Director for Special Initiatives, Office of the Director, National Center for Advancing Translational Sciences, National Institutes of Health
Dario Doller, PhD, Sage Therapeutics
David Barbie, MD, Assistant Professor, Medical Oncology, Dana-Farber Cancer Institute
David Duignan, PhD, Principal Research Scientist, Drug Metabolism, Pharmacokinetics & Bioanalysis, AbbVie Bioresearch Center
David J. Echevarria, PhD, Associate Professor, Director, Behavioral Neuroscience Laboratory, Department of Psychology, University of Southern Mississippi
David Nguyen, PhD, Principal Scientist, SAGE Therapeutics
David Schaer, Principal Research Scientist, Cancer Immunobiology Experimental and Translational Immuno-Oncology Group, Eli Lilly and Company
Dazhong Xu, PhD, Assistant Professor of Pathology, Vice Chair of Research, Department of Pathology, New York Medical College School of Medicine
Deborah Pre, PhD, Scientist, Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute
Deepak Kumar Rajpal, Ph.D., Director, Computational Biology, GlaxoSmithKline
Denise Barrault, PhD, Executive Director, National Phenotypic Screening Centre
Denise L. Faustman, MD, PhD, Director, Immunobiology, Massachusetts General Hospital; Associate Professor, Medicine, Harvard Medical School
Dimitrios Tzalis, PhD, CEO, Taros Chemicals GmbH & Co. KG
Donglu Zhang, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.
Doo Yeon Kim, PhD, Assistant Professor of Neurology, Genetics and Aging Research Unit, Massachusetts General Hospital / Harvard Medical School
Doug Johnson, PhD, Research Fellow, Head of Chemical Biology, Pfizer Worldwide Research & Development
Duncan Armstrong, PhD, PreClinical Safety, Novartis Institutes for BioMedical Research
Edgar Wood, Senior Research Director, Discovery, Charles River
Edward J. Hennessy, PhD, Associate Principal Scientist, Oncology iMed, AstraZeneca
Ekta Kadakia, MS, Scientist 1, DMPK, Takeda
Elisa Konofagou, Professor, Biomedical Engineering, Columbia University
Elizabeth Evans, PhD, Vice President, Preclinical Research, Vaccinex, Inc.
Emer Leahy, PhD, President, CEO, PsychoGenics Inc.
Eric Goedken, PhD, Principal Scientist, Foundational Immunology, AbbVie Bioresearch Center
Eric Karran, PhD, Vice President, Foundational Neuroscience Center, AbbVie Neuroscience, AbbVie
Eric Marsault, PhD, Professor, Medicinal Chemistry and Pharmacology, University of Sherbrooke
Fabian Zanella, Director, Research & Development, StemoniX
Fabien Vincent, PhD, Associate Research Fellow, Hit Discovery and Lead Profiling Group, Pfizer
Fangxian (Frank) Sun, Lead Research Investigator, Pharmacology, Sanofi
Francisco Garcia, PhD, Associate Scientist/Postdoctoral Research Fellow, Chemical Biology and Proteomics, Merck Research Laboratories
Ganesh Rajaraman, PhD MBA, Associate Director, DMPK, Celgene Corporation
Gary Gintant, PhD, Senior Research Fellow, Department of Integrative Pharmacology, Integrated Science and Technology, AbbVie
Geoffrey Bartholomeusz, PhD, Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Georgette L. Suidan, PhD, Principal Scientist, Lab Head, Internal Medicine Research Unit, Pfizer, Inc.
Gopi Shanker, PhD, Head of Psychiatry, Neuroscience Department, Novartis Institutes for Biomedical Research (NIBR)
Graham Dempsey, PhD, Vice President, Research and Development, Q-State Biosciences
Greg Johnson, PhD, Scientist & Machine Learning Specialist, Allen Institute for Cell Science
Gregory Tietjen, PhD, Assistant Professor, Department of Surgery, Section of Transplantation and Immunology, Yale School of Medicine
Guido Grandi, PhD, Professor, Synthetic and Structural Vaccinology - CIBIO, University of Trento, Formerly Senior Project Leader, Novartis Vaccines and Diagnostics
Gulden Camci-Unal, PhD, Assistant Professor, Chemical Engineering, University of Massachusetts Lowell
Gus Frangou, PhD, Assistant Professor of Oncology, Department of Cancer Genetics, Roswell Park Cancer Institute; Senior Fellow, Harvard T.H. Chan School of Public Health
H. James Harwood Jr., PhD, Founder and CEO, Delphi BioMedical Consultants, LLC
Helmut Thomas, PhD, DABT, President and CEO, Cyclenium Pharma, Inc.
Hicham Fenniri, PhD, Professor, Chemical and Biomedical Engineering, Northeastern University
Hossein Tavana, PhD, PEng, Associate Professor, Department of Biomedical Engineering, The University of Akron
Ibrahim Domian, MD, PhD, Assistant Physician, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Istvan Enyedy, PhD, Principal Scientist, Medicinal Chemistry, Biogen
Ivan Cornella Taracido, PhD, Director, Chemical Biology, Merck Research Laboratories
J. Henri Bayle, PhD, Director of Discovery, Bellicum Pharmaceuticals, Inc.
Jacob M. Hooker, PhD, Phyllis and Jerome Lyle Rappaport MGH Research Scholar, Associate Professor of Radiology, Harvard Medical School
James Dahlman, PhD, Assistant Professor, Department of Biomedical Engineering, Georgia Institute of Technoloy/Emory Medical School
James J. Hickman, PhD, Founding Director, NanoScience Technology Center; Professor, Nanoscience Technology, Chemistry, Biomolecular Science, Material Science and Electrical Engineering, University of Central Florida
Jan Lötvall, MD, PhD, Professor, Krefting Research Centre, University of Gothenburg; Senior Consultant, Codiak BioSciences, Inc.
Janica Wong, PhD, Senior Scientist, Translational Pathology, Merck Research Labs
Jean Viallet, PhD, CEO, CSO, Inovotion
Jeff Borenstein, PhD, Laboratory Technical Staff, Biomedical Microsystems, Draper
Jeffrey Borenstein, PhD, Laboratory Technical Staff, Biomedical Microsystems, Draper
Jennifer Brogdon, PhD, Director, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research
Jennifer Mataraza, PhD, Group Lead, Translational Immuno-Oncology, Novartis Institutes for BioMedical Research
Jennifer Smith, PhD, Deputy Director, ICCB-Longwood Screening Facility, Harvard Medical School
Jens Eckstein, PhD President, SR One
Jeremey Edmunds, PhD, Director, Immunology Medicinal Chemistry, AbbVie
Jeremy Jenkins, PhD, Executive Director, Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research
Jerome Mertens, PhD, Salk Institute
Jesus Medina, PhD, Manager, Medicinal Chemistry, GlaxoSmithKline
Jialin Mao, PhD, Senior Scientist, DMPK, Genentech
Jiangbing Zhou, Assistant Professor of Neurosurgery and of Biomedical Engineering, Department of Neurosurgery, Yale University
Jinjun Shi, PhD, Assistant Professor, Harvard Medical School; Director, Laboratory for Nanoengineering & Drug Delivery, Brigham and Women’s Hospital
Joern Hopke, PhD, Senior Research Investigator, Sanofi Biologics Research
Johan Luthman, PhD, Vice President, Neuroscience Clinical Development, Neurology Business Group, Eisai, Inc.
Johannes Grosse, PhD, Director, Neuroscience Drug Discovery/Alliances, Takeda
John Doench, PhD, Associate Director, Genetic Perturbation Platform, Broad Institute of Harvard and MIT
John Feder, PhD, Associate Director of Genome Biology and Emerging Technologies, Department of Genetically Defined Diseases and Genomics, Bristol-Myers Squibb
John Gregory, Director, R&D Project & Portfolio Management Business Technology, Pfizer
John MacMillan, PhD, Professor, Chemistry and Biochemistry, University of California, San Diego
John Mathias, PhD, Senior Director, Head of Inflammation & Immunology Design, Pfizer
John Pezacki, PhD, Professor, Chemistry and Biomolecular Sciences, University of Ottawa
John Reilly, PhD, Senior Research Investigator, Global Chemistry, Novartis
John Swart, PhD, President, Exemplar Genetics
John Wambaugh, PhD, Physical Scientist, National Center for Computational Toxicology, U.S. Environmental Protection Agency
Jonathan Dry, Principal Scientist, Bioinformatics, Oncology, Innovative Medicines & Early Development, AstraZeneca
Jonathan Garlick, DDS, PhD, Professor, School of Dental Medicine, Tufts University; Director, Division of Cancer Biology and Tissue Engineering, Tufts School of Medicine, School of Engineering and Sackler School of Graduate Biomedical Sciences
Jonathan Shewring, PhD, Field Application Specialist, ONI
Joseph Bonventre, MD, PhD, Chief of the Renal Unit, Director of the Bioengineering Division, Brigham and Women’s Hospital
Joseph Charest, PhD, Program Manager, Commercial Programs, Draper
Joseph Moskal, PhD., CSO, Aptinyx
Karen DeBalsi, PhD, Study Director, Metabolon
Karin Enell Smith, PhD, Senior Scientist, Preclinical Development, Alligator Bioscience AB
Katherine Chiappinelli, PhD, Assistant Professor, Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University
Keisuke Yanagida, PhD, Research Fellow, Vascular Biology Program, Boston Children’s Hospital/Harvard Medical School
Keith L. Ligon, MD, PhD, Director, Department of Oncologic Pathology, Center for Patient Derived Models, Dana-Farber Cancer Institute
Ken Hance, Senior Director & Head, Immune Biology, Immuno-Oncology & Combinations Discovery Performance Unit, GlaxoSmithKline
Kent Werner, MD, PhD, Co-Founder and CEO, Cogentis Therapeutics; Johns Hopkins Neurology Adjunct Faculty
Kevin Bitterman, PhD, Partner, Atlas Venture
Kevin Holden, PhD, Head, Synthetic Biology, Synthego
Kilian Huber, PhD, Principal Investigator, Structural Genomics Consortium (SGC), Target Discovery Institute, Nuffield Department of Medicine, University of Oxford
Kin-Hoe Chow, PhD, Associate Director, Center for Patient Derived Models, Dana-Farber Cancer Institute
Kuan-Chun Su, PhD, Post-doctoral Fellow, Laboratory of Iain Cheeseman, Department of Biology, MIT and Whitehead Institute
Laszlo Urban, MD, PhD, Global Head, Preclinical Secondary Pharmacology, Novartis Institutes for Biomedical Research
Leigh Zawel, PhD, Managing Director, MPM Capital
Leo Chan, Technology Research & Development Manager, Nexcelom Bioscience LLC
Leo Price, PhD, CEO, OcellO
Li Di, PhD, Research Fellow, Pharmacokinetics, Dynamics and Metabolism, Pfizer
Li Peng, PhD, Vice President, Biotherapeutics Discovery, Palleon Pharmaceuticals
Lijun Sun, PhD, Director, Center for Drug Discovery and Translational Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Lorraine Irving, PhD, Research Scientist, MedImmune
Lyn Jones, PhD, Vice President, Chemistry and Chemical Biology, Jnana Therapeutics
Madhu Lal-Nag, PhD, Group Leader, Trans-NIH RNAi Facility, National Center for Advancing Translational Sciences, National Institutes of Health
Marc Ferrer, PhD, Team Lead, NIH Chemical Genomics Center, NCATS, NIH
Marco Ruella, MD, Clinical Instructor, Associate Director, Dr. June’s Laboratory, Center for Cellular Immunotherapies (CCI), Perelman School of Medicine, University of Pennsylvania
Marcus Bosenberg, MD, PhD, Associate Professor, Dermatology and Pathology, Yale University, Co-Leader, Genomics, Genetics and Epigenetics Program, Yale Cancer Center
Margaret Prendergast, Director, Bioengineering, Allevi, Inc.
Margarida Barroso, PhD, Associate Professor, Department of Molecular and Cellular Physiology, Albany Medical College
Maria A. Miteva, PhD, Research Director, Molécules Thérapeutiques in silico (MTi), Inserm Institute
Maria Karasarides, PhD, Executive Director, Immuno-Oncology, Regeneron Pharmaceuticals
Mario Gimona, PhD, Head of Production GMP & Head of Research Program “Nanovesicular Therapeutics”, GMP Unit, Paracelsus Medical University Salzburg
Mark A. Murakami, MD, Instructor in Medicine, Department of Medical Oncology, Dana-Farber Cancer Institute
Mark Paris, PhD, Associate Director, Translational Applications, Mitra Biotech
Mark Peterson, PhD, COO, Cyclenium Pharma, Inc.
Maryam Clausen, PhD, Senior Research Scientist, Translational Genomics, Discovery Sciences, Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca
Matt Wagoner, Associate Director, Mechanistic and Investigative Toxicology, Takeda Pharmaceuticals
Matthew M. Hewitt, PhD, Principal Scientist, Tumor Biology & Director, Tumor Immunology/Microenvironment, Research & Development, Bellicum Pharmaceuticals, Inc.
Maude Tessier, Executive Director, Business Development, Merck
Max Woolley, PhD, BEng (Hons), BEng, Neuro Applications, Renishaw plc
Meir Glick, PhD, Director, Informatics, Chemistry, Merck Research Laboratories
Melissa Thomas, MD, PhD, Medical Fellow, Diabetes and Complications, Eli Lilly and Company
Michael Gladstone, MD, Principal, Atlas Venture
Michael Hiatt, PhD, Senior Scientist, Research & Development, STEMCELL Technologies Inc.
Michael Sasner, PhD, Co-Director, Disease Modeling Program, MODEL-AD Cente
Michael Woo, PharmD, MBA, Head, Search & Evaluation, Immuno-Oncology, External Innovation, EMD Serono Research & Development Institute
Mingxiang Liao, PhD, Associate Director, Clinical Pharmacology and DMPK, Clovis Oncology
Mithun Khattar, PhD, Immuno-Oncology Lead, Cancer Pharmacology, Takeda Pharmaceuticals
Monica Moya, PhD, Research Engineer, Materials Engineering Division, Lawrence Livermore National Laboratory
Moony (Yuen-Yi) Tseng, PhD, Group Leader, Research Scientist, Cancer Program, The Broad Institute of MIT and Harvard
Morteza Mahmoudi, PhD, Instructor, Center for Nanomedicine and Department of Anesthesiology, BWH, Harvard Medical School
Murali Gopalakrishnan, PhD, MBA, Senior Director, Head, Search & Evaluation Neuroscience, AbbVie
Neil Grimster, Senior Scientist, Oncology Chemistry, AstraZeneca
Nick Iannotti, PhD, Manager, Precision Medicine Technology, R&D Business Technology, Pfizer
Nicole Meisner-Kober, PhD, Scientific Director, Research Studios Austria, University of Salzburg, Formerly Senior Investigator, Novartis Institutes for Biomedical Research
Niek Dekker, PhD, Principal Scientist, Discovery Sciences, AstraZeneca
Nikolai Tupitsyn, PhD, Professor, Cancer Immunology, Lab, Blokhin Cancer Research Center
Nilesh Kumar, PhD, Partner, Novo Ventures
Nisha S. Sipes, PhD, Health Science Evaluator, Biomolecular Screening Branch/Toxicoinformatics Group, National Toxicology Program Division, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health
Norman Greenberg, PhD, CSO and Senior Vice President, Therapeutics, Atreca
Oleg Butovsky, PhD, Assistant Professor of Neurology, Harvard Medical School, Associate Scientist, Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital
Patrick Mayes, PhD, Executive Director, Head, IO Antibody Research, Incyte
Paul Robbins, PhD, Professor and Director of the TSRI Center on Aging, Molecular Medicine, The Scripps Research Institute
Paul Trippier, PhD, Professor, Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center
Peter Lobel, PhD, Professor, Center for Advanced Biotechnology and Medicine, Rutgers University
Peter Reinhardt, PhD, Head, Cell Programming and Transduction, Technology Core, Neuroscience Discovery, AbbVie
Peter Searson, PhD, Professor, Institute for Nanobiotechnology, Johns Hopkins University
Peter Tonge, PhD, Professor, Chemistry, Stony Brook University
Philip Carpino, PhD, Associate Research Fellow, Medicine Design, Pfizer
Philippe Slos, PhD, Study Director, Oncodesign
Ping Chiao, PhD, Senior Director, Translational Biomarkers, Neuroscience, Biogen
Piyush Bajaj, PhD, Scientist II, Investigative Toxicology, Drug Safety Research and Evaluation, Takeda Pharmaceuticals
Pooja Jain, MSc, MBA, Product Manager, R&D Solutions, Elsevier
Priyanka Kulkarni, PhD, Scientist, Pharmacokinetics and Drug Metabolism, Amgen, Inc.
Qin Wang, PhD, Principal Scientist, Translational Sciences, Biogen
Quamrul Hassan, PhD, Group Leader, Molecular and Cellular Pharmacology, EMD Serono
Rafael Fernandez, PhD, Principal Scientist, Pharmacology, Merck Research Laboratories
Ramesh Jayaraman, CSO, TheraIndx Lifesciences Pvt Ltd
Randolph Corteling, PhD, Head of Research, R&D, ReNeuron, Ltd.
Rangaraj Narayanan, PhD, Director, Drug Metabolism and Pharmacokinetics, Shire Pharmaceuticals
Raymond Chung, PhD, Biomedical Research Scientist, Cardiovascular Research, Regeneron Pharmaceuticals
Regis Doyonnas, PhD, Senior Principal Scientist, Primary Pharmacology Group, High Content Screening Lead, Worldwide R&D, Pfizer
Renato (Ron) Scialis, PhD, Senior Research Investigator, Preclinical Candidate Optimization, Bristol-Myers Squibb
Richard J. Price, PhD, Professor, Biomedical Engineering, University of Virginia
Ricky Solorzano, CEO, Allevi, Inc.
Robert A. Rollins, PhD, Associate Director, Oncology Research & Development, Pfizer
Robert C. Switzer, III, PhD, President, CSO, NeuroScience Associates, Inc.
Roderick L. Beijersbergen, PhD, Group Leader, Division of Molecular Carcinogenesis and Head, NKI Robotics and Screening Center, The Netherlands Cancer Institute
Ronald Alfa, MD, PhD, Vice President, Discovery & Product, Recursion Pharmaceuticals
Ronald Herbst, PhD, Vice President, R&D and Head, Oncology Research, MedImmune
Ronald Tomlinson, Associate Principal Scientist, Discovery Sciences – Chemical Biology, AstraZeneca
Ruben Boado, PhD, Vice President, Research & Development/Co-Founder, ArmaGen, Inc.
Rui Wang, PhD, Senior Scientist, Department of Immunology, AbbVie Bioresearch Center
Ruth Maclean, Senior Client Manager, Charles River
Ryan Nolan, PhD, Research Fellow, Takeda Pharmaceuticals International Co.
S. Joshua Swamidass, MD, PhD, Assistant Professor, Department of Immunology and Pathology, Division of Laboratory and Genomic Medicine; Faculty Lead, Translational Informatics, Institute for Informatics, Washington University
Samantha A. Meenach, PhD, Assistant Professor, Department of Chemical Engineering, Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island
Samira Musah, PhD, Dean’s Postdoctoral Fellow, Wyss Institute at Harvard University and Harvard Medical School
Samit Bhattacharya, PhD, Senior Principal Scientist, World Wide Medicinal Chemistry, Pfizer
Sarah Boswell, PhD, Director of Sequencing Technologies, Laboratory of Systems Pharmacology and Director, Single-Cell Sequencing Core, Harvard Medical School
Saso Cemerski, PhD, Principal Scientist, Merck Research Labs
Sean Lawler, PhD, Assistant Professor & Managing Director, Harvey Cushing Neurooncology Laboratories, Neurosurgery, Brigham and Women’s Hospital
Serguei Kozlov, PhD, MBA, PMP, Principal Scientist/PM, Team Leader PTO, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)
Shane Horman, PhD, Research Investigator III, Genomic Institute of the Novartis Research Foundation
Shantanu Singh, PhD, Senior Group Leader, Imaging Platform, Broad Institute
Shay Soker, PhD, Professor, Regenerative Medicine, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine
Shila Mekhoubad, PhD, Scientist II, Stem Cell Research, Biogen
Shuang Chen, PhD, Postdoctoral Fellow, Oncology Research Unit, Pfizer
Simone Calzolari, MSc, PhD, Co-Founder, Chief Commercial Officer, ZeClinics S.L.
Siva Kumar Belliraj, PhD, Associate Professor, Department of Chemistry, Sri Sathya Sai Institute of Higher Learning
Sourav Ghosh, PhD, Associate Professor, Neurology and Pharmacology, Yale University School of Medicine
Srivatsan Raghavan, MD, PhD, Instructor, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute
Stefan Braam, PhD, Technical Director, Ncardia
Stefan Wilhelm, PhD, Assistant Professor, Stephenson School of Biomedical Engineering, University of Oklahoma
Stéphanie Boué, Manager Scientific Transparency & Verification, PMI R&D, Philip Morris Products S.A., Part of Philip Morris International Group
Stéphanie Decollogne, PhD, Senior Manager, Preclinical & Toxicology, Clinical Development, Nanobiotix
Stephanie Mohr, PhD, Lecturer, Genetics & Director, Drosophila RNAi Screening Center at Harvard Medical School
Stephen S. Ferguson, PhD, Chemist, Division of the National Toxicology Program (NTP), Biomolecular Screening Branch (BSB) & NTP Laboratories, National Institute of Environmental Health Sciences (NIEHS)
Stevin Zorn, PhD, President and CEO, MindImmune Therapeutics, Inc.
Svetlana Belyanskaya, PhD, Scientific Leader, Encoded Library Technologies, R&D Platform Technology & Science, GSK Boston
Swetha Srinivasan, PhD, Postdoctoral Fellow, Translational Immunology, AbbVie, Inc.
Takaomi C. Saido, PhD, Laboratory Head, Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute
Terry Kenakin, PhD, Professor, Department of Pharmacology, University of North Carolina School of Medicine
Terry Van Vleet, PhD, DABT, Head of Molecular and Computational Toxicology, Department of Preclinical Safety, Abbvie
Thierry Dorval, PhD, HCS Group Leader, Institut de Recherches Servier
Thomas M. Monticello, DVM, PhD, Executive Director, Comparative Biology and Safety Sciences, Amgen
Tim Bauler, PhD, Assistant Professor, Department of Biomedical Sciences, Western Michigan University Homer Stryker M.D. School of Medicine
Timothy Majarian, Associate Computational Biologist, Broad Institute
Tom Sundberg, PhD, Senior Research Scientist I, Center for the Development of Therapeutics, Broad Institute of MIT and Harvard
Tomoki Yoneyama, PhD, Senior Scientist 1, DMPK, Takeda
Tuulia Huhtala, PhD, Head, Biomarkers and in vitro Biology, Discovery, Charles River
Ulrich Elling, PhD, Principle Investigator, Institute of Molecular Biotechnology Austria (IMBA)
Vladimir Torchilin, PhD, Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Bouvé College of Health Sciences, Northeastern University
Warren J. Leonard, MD, NIH Distinguished Investigator, Chief, Laboratory of Molecular Immunology and Director, Immunology Center, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health
Wayne W. Hancock, MD, PhD, Professor of Pathology and Chief of Transplant Immunology, Children’s Hospital of Philadelphia and University of Pennsylvania
Wen Kang, PhD, Principal Scientist, Safety Assessment & Laboratory Animal Resources, Merck & Co., Inc.
Will Proctor, PhD, Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech
William A. Banks, MD, Associate Chief of Staff – R&D, Geriatric Research Education & Clinical Center, Veterans Affairs Medical Center & University of Washington
William Daly, PhD, Managing Director & Faculty Scientist, Orthopedics and Rehabilitation, University of Wisconsin - Madison
William Proctor, PhD, Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech
Xingfeng Bao, PhD, Head, Immuno-Oncology, Integrated Biology Engine, Eisai AiM Institute, Eisai, Inc.
Xingxing Zang, PhD, Louis Goldstein Swan Endowed Chair and Professor, Microbiology and Immunology & Medicine, Albert Einstein College of Medicine
Ying Wang, PhD, Principal Scientist, Department of Chemistry & Technology, AbbVie
Yu Shrike Zhang, PhD, Research Faculty & Associate Bioengineer, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School & Harvard-MIT Division of Health Sciences and Technology
Yuan Chen, PhD, Principal Scientist, DMPK, Genentech
Zhao Chen, PhD, Investigator III, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research
Zhengyin Yan, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.